Faculty profile

Sheena Taha

ResearcherClinical EpidemiologyUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.

Sheena Taha

Researcher

Clinical Epidemiology

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
8 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2017.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

108

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Core Outcomes Network Meta-Analysis Opioid Use Disorder Psychosocial Survey Systematic Review Treatment

Latest papers

Challenges and opportunities in embedding core components of substance use health care into Housing First programs.
Frontiers in public health · 2026
Multi-level barriers and facilitators to buprenorphine use in Ontario, Canada: a qualitative study using the theoretical domains framework.
Addiction science & clinical practice · 2025
An integrated knowledge mobilization approach to substance use health.
Health research policy and systems · 2025 · first author

All 14 publications

Latest funding

Evaluating Ontario's rapid access addiction medicine (RAAM) model of care to address the Canadian opioid crisis
CIHR · 2018 · Co-investigator
$96,962
Comparing Psychosocial Interventions and Establishing Core Outcomes for Treatment of Opioid Use Disorder
CIHR · 2017 · Principal investigator
$108,100

All 2 grants and awards

14 publications.

Challenges and opportunities in embedding core components of substance use health care into Housing First programs.

Somefun OD, Stergiopoulos V, Taha S, Kerman N, Buckley L, Aubin N, Caudarella A, Juhasz SC, McCrone KM, Millward J, Mirabelli T, Corace K

Frontiers in public health2026

DOI: 10.3389/fpubh.2026.1817752 PMID: 42718462

Multi-level barriers and facilitators to buprenorphine use in Ontario, Canada: a qualitative study using the theoretical domains framework.

Leece P, Khorasheh T, Zerger S, Corace K, Nixon L, Strike C, Bayomi AM, Marks E, Holowaty M, Crichlow F, Taha S, Straus SE

Addiction science & clinical practice2025

DOI: 10.1186/s13722-025-00610-w PMID: 41121195

An integrated knowledge mobilization approach to substance use health.

Taha S, Wood S, Sondagar C, Helis E, Payer D, Hernandez-Basurto M

Health research policy and systems2025First author

DOI: 10.1186/s12961-025-01313-z PMID: 40176118

Evaluation of the outcomes of equity-deserving individuals receiving services and support from integrated substance use health and mental health services: a pilot study protocol.

Edalati H, Katan C, Taha S

Frontiers in psychiatry2024Senior author

DOI: 10.3389/fpsyt.2024.1425514 PMID: 39720432

Changes in harm reduction service providers professional quality of life during dual public health emergencies in Canada.

Taha S, King S, Atif S, Bate E

Harm reduction journal2024First author

DOI: 10.1186/s12954-024-00966-3 PMID: 38388932

Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid-related health problems: a population-based retrospective cohort study.

Paul LA, Bayoumi AM, Chen C, Kocovska E, Smith BT, Raboud JM, Gomes T, Kendall C, Rosella LC, Bitonti-Bengert L, Rush B, Yu M, Spithoff S, Crichlow F, Wright A, Watford J, Besharah J, Munro C, Taha S, Nosyk B, Strike C, Manson H, Kahan M, Leece P

Addiction (Abingdon, England)2023

DOI: 10.1111/add.16096 PMID: 36401610

Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use

Corace K, Thavorn K, Suschinsky K, Willows M, Leece P, Kahan M, Nijmeh L, Aubin N, Roach M, Garner G

JAMA Network Open202315 citationsOpen Access

DOI: 10.1001/jamanetworkopen.2023.44528 PMID: W4388907469

Supporting community overdose response planning in Ontario, Canada: Findings from a situational assessment.

Khorasheh T, AbuAyyash CB, Mallakin M, Sellen K, Corace K, Pauly B, Buchman D, Hamilton M, Boyce N, Ng K, Strike C, Taha S, Manson H, Leece P

BMC public health2022

DOI: 10.1186/s12889-022-13762-0 PMID: 35854231

Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses

Rice D, Corace K, Wolfe D, Esmaeilisaraji L, Michaud A, Grima A, Austin B, Douma R, Barbeau P, Butler C

PLoS ONE202060 citations

DOI: 10.1371/journal.pone.0244401

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review.

Leece P, Khorasheh T, Corace K, Strike C, Bayoumi AM, Taha S, Marks E, Pach B, Ahamad K, Grennell E, Holowaty M, Manson H, Straus SE

BMJ open2019

DOI: 10.1136/bmjopen-2019-032285 PMID: 31843837

Something wrong or missing on this profile? Suggest a correction

Sheena Taha

Research

Latest papers

Latest funding

Challenges and opportunities in embedding core components of substance use health care into Housing First programs.

Multi-level barriers and facilitators to buprenorphine use in Ontario, Canada: a qualitative study using the theoretical domains framework.

An integrated knowledge mobilization approach to substance use health.

Evaluation of the outcomes of equity-deserving individuals receiving services and support from integrated substance use health and mental health services: a pilot study protocol.

Changes in harm reduction service providers professional quality of life during dual public health emergencies in Canada.

Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid-related health problems: a population-based retrospective cohort study.

Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use

Supporting community overdose response planning in Ontario, Canada: Findings from a situational assessment.

Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review.

Evaluating Ontario's rapid access addiction medicine (RAAM) model of care to address the Canadian opioid crisis

Comparing Psychosocial Interventions and Establishing Core Outcomes for Treatment of Opioid Use Disorder

Frequent collaborators

Pamela Leece

Carol Strike

Heather Manson

Kednapa Thavorn

Gary Garber

Melanie Willows

Kimberly Corace

Danielle Rice

Brian Hutton

Kednapa Thavorn

Amy Porath

David Moher

Gary Garber

Danielle Rice

Brian Rush

Sheryl Spithoff

Amy Wright

Kednapa Thavorn

Leslie Buckley

Rita Henderson

Lara Nixon

Rita Henderson

Bohdan Nosyk

Beverley Shea

Keith Ahamad

Daniel Buchman

Tara Gomes

Jane Buxton

Claire Kendall

Vicky Stergiopoulos

Patricia Poulin

Bernadette Pauly

Vicky Stergiopoulos

Bohdan Nosyk